871101-87-0

Basic information

• Product Name: 1-(3-aMino-4-(benzyloxy)-2-hydroxyphenyl)ethanone
• Synonyms: 1-(3-aMino-4-(benzyloxy)-2-hydroxyphenyl)ethanone
• CAS NO: 871101-87-0
• Molecular Formula: C₁₅H₁₅NO₃
• Molecular Weight: 257.2845
• Mol File: 871101-87-0.mol

Chemical Properties

• Appearance: /
• Storage Temp.: Keep in dark place,Inert atmosphere,Room temperature
• CAS DataBase Reference: 1-(3-aMino-4-(benzyloxy)-2-hydroxyphenyl)ethanone(CAS DataBase Reference)
• NIST Chemistry Reference: 1-(3-aMino-4-(benzyloxy)-2-hydroxyphenyl)ethanone(871101-87-0)
• EPA Substance Registry System: 1-(3-aMino-4-(benzyloxy)-2-hydroxyphenyl)ethanone(871101-87-0)

Safety Data

• Hazardous Substances Data: 871101-87-0(Hazardous Substances Data)

Usage

Uses

Used in Pharmaceutical Synthesis:
1-(3-amino-4-(benzyloxy)-2-hydroxyphenyl)ethanone is used as an intermediate in the pharmaceutical industry for the synthesis of various drugs. Its unique structure allows for the development of new therapeutic agents with potential applications in treating a range of medical conditions.
Used in Agrochemical Production:
In the agrochemical industry, 1-(3-amino-4-(benzyloxy)-2-hydroxyphenyl)ethanone is used as a precursor for the production of various pesticides and insecticides. Its structural features make it a valuable component in the creation of effective and targeted agrochemicals.
Used in Medicinal Chemistry Research:
Due to its structural similarity to certain bioactive molecules, 1-(3-amino-4-(benzyloxy)-2-hydroxyphenyl)ethanone is used as a research compound in medicinal chemistry. It serves as a starting point for the design and development of new pharmaceuticals with improved efficacy and reduced side effects.
Used in Organic Chemistry:
As a substituted phenethylamine with a benzyl ether group and a hydroxy group, 1-(3-amino-4-(benzyloxy)-2-hydroxyphenyl)ethanone is used in organic chemistry for the synthesis of a wide range of organic compounds. Its versatility makes it a valuable building block for the creation of new chemical entities with various applications.

Upstream product

• 1035229-31-2 1-(4-(benzyloxy)-2-hydroxy-3-nitrophenyl)ethanone 
• 89684-58-2 1-(2,4-dihydroxy-3-nitrophenyl)ethanone 
• 601-89-8 2-nitroresorcinol 

Downstream Products

• 869868-50-8 7-acetyl-4-benzyloxy-3H-benzoxazol-2-one 
• 869868-56-4 8-acetyl-5-benzyloxy-2,2-dimethyl-4H-benzo[1,4]oxazin-3-one 
• 1035229-32-3 8-acetyl-5-(benzyloxy)-2H-benzo[b][1,4]oxazin-3(4H)-one 
• 1035229-33-4 5-(benzyloxy)-8-(2-chloroacetyl)-2H-benzo[b][1,4]oxazin-3(4H)-one 
• 1035229-34-5 8-(2-azidoacetyl)-5-(benzyloxy)-2H-benzo[b][1,4]oxazin-3(4H)-one 
• 1035229-43-6 tert-butyl(2-(N-cyclohexylacrylamido)ethyl)(2-(5-hydroxy-3-oxo-3,4-dihydro-2H-benzo[b][1,4]oxazin-8-yl)ethyl)carbamate 
• 1035227-29-2 N-cyclohexyl-N-(2-((2-(5-hydroxy-3-oxo-3,4-dihydro-2H-benzo[b][1,4]oxazin-8-yl)ethyl)amino)ethyl)-3-(phenethylamino)-propanamide 
• 1092407-74-3 5-benzyloxy-8-((R)-2-chloro-1-hydroxy-ethyl)-4H-benzo[1,4]oxazin-3-one 
• 1092407-75-4 5-benzyloxy-8-[(R)-1-(tert-butyl-dimethyl-silanyloxy)-2-chloro-ethyl]-4H-benzo[1,4]oxazin-3-one 
• 1092407-76-5 8-[(R)-2-azido-1-(tert-butyl-dimethyl-silanyloxy)-ethyl]-5-benzyloxy-4H-benzo[1,4]oxazin-3-one 
• 1201640-17-6 N-cyclohexyl-N-(2-(2-(5-hydroxy-3-oxo-3,4-dihydro-2H-benzo[b][1,4]oxazin-8-yl)ethylamino)ethyl)-3-(3-(1-methyl-1H-imidazol-2-yl)phenethoxy)propanamide 
• 1201639-56-6 N-cyclohexyl-N-(2-{[2-(5-hydroxy-3-oxo-3,4-dihydro-2H-1,4-benzoxazin-8-yl)ethyl]amino}ethyl)-3-{2-[3-(1-methyl-1H-pyrazol-4-yl)phenyl]ethoxy}propanamide 
• 1201640-09-6 N-cyclohexyl-3-(3-(1-ethyl-1H-pyrazol-4-yl)phenethoxy)-N-(2-(2-(5-hydroxy-3-oxo-3,4-dihydro-2H-benzo[b][1,4]oxazin-8-yl)ethylamino)ethyl)propanamide 
• 1201640-47-2 tert-butyl 2-(3-(3-bromophenethoxy)-N-cyclohexylpropanamido)ethyl(2-(5-hydroxy-3-oxo-3,4-dihydro-2H-benzo[b][1,4]oxazin-8-yl)ethyl)carbamate 

Relevant articles and documents

SMYD2 INHIBITORS

The present disclosure generally relates to compounds having cellular anti-proliferative activities, and more particularly relates to compounds which inhibit the activity of human SMYD2, a SET and MYND domain-containing protein lysine methyltransferase.

Discovery of A-893, A New Cell-Active Benzoxazinone Inhibitor of Lysine Methyltransferase SMYD2

A lack of useful small molecule tools has precluded thorough interrogation of the biological function of SMYD2, a lysine methyltransferase with known tumor-suppressor substrates. Systematic exploration of the structure-activity relationships of a previous

BENZOXAZINONE DERIVATIVES ACTING AS BETA2-ADRENORECEPTOR AGONIST FOR THE TREATMENT OF RESPIRATORY DISORDERS

The present invention provides a compound of formula (I), wherein W, R1, R2 and R3 are as defined in the specification, processes for their preparation, pharmaceutical compositions containing them and their use in therapy.

AMINE DERIVATIVES AND THEIR USE IN BETA-2-ADRENORECEPTOR MEDIATED DISEASES

The present invention provides compounds of formula (I), wherein k, Ar, R2, R3, R4, R5, R4', R5', R6, R7, A, D, m and E are as defined in the specification, processes